Get started
Author

Leyla Norouzi‐Barough

Observed names: Leyla Norouzi Barough, Leyla Norouzi-Barough, Norouzi-Barough Leyla
ORCID: 0000-0002-8699-9665
Observed ORCID: 0000-0002-8699-9665
OpenAlex ID: A5081814101
Molecular mechanisms of drug resistance in ovarian cancer
2017 · Leyla Norouzi‐Barough, Mohammad Reza Sarookhani, et al. · Journal of Cellular Physiology · 207
CRISPR/Cas9, a new approach to successful knockdown of ABCB1/P-glycoprotein and reversal of chemosensitivity in human epithelial ovarian cancer cell line.
2018 · Leyla Norouzi-Barough, Mohammadreza Sarookhani, et al. · PubMed Central · 38
PDF
Early diagnosis of breast and ovarian cancers by body fluids circulating tumor-derived exosomes
2020 · Leyla Norouzi-Barough, Amir Asgari Khosro Shahi, et al. · Cancer Cell International · 36
PDF
Therapeutic potential of mesenchymal stem cell-derived exosomes as a cell-free therapy approach for the treatment of skin, bone, and cartilage defects
2021 · Leyla Norouzi-Barough, Sadegh Shirian, et al. · Connective Tissue Research · 26
COVID-19-Induced Stroke and the Potential of Using Mesenchymal Stem Cells-Derived Extracellular Vesicles in the Regulation of Neuroinflammation
2022 · Leyla Norouzi-Barough, Amir Asgari Khosroshahi, et al. · Cellular and Molecular Neurobiology · 18
PDF
Highly sensitive mixed molecular nanostructures of glutamine and doxorubicin on gold for targeted recognition of A2780 cancer cells using impedance spectroscopy and quartz crystal microbalance
2021 · Fatemeh Yaghoobi, Zahra Al-Sadat Davoudi, et al. · Sensors and Actuators B Chemical · 5
Fabrication of a biocompatible & biodegradable targeted theranostic nanocomposite with pH-Controlled drug release ability
2022 · Hassan Arkaban, Reza Karimi Shervedani, et al. · Journal of Drug Delivery Science and Technology · 4
A Systematic Review of Mendelian Pyoderma Gangrenosum: Clinical and Genetic Characteristics in 120 Published Patients
2025 · Leyla Norouzi‐Barough, Sajjad Biglari, et al. · Experimental Dermatology · 3
PDF
A novel ITGB2 variant in a patient with severe recurrent pyoderma gangrenosum-like lesions and underlying leukocyte adhesion deficiency type I: case report and literature review
2025 · Leyla Norouzi-Barough, Nasrin Alipour Olyaei, et al. · Archives of Dermatological Research · 3
Guillain–Barré syndrome (GBS) after severe/critical COVID-19 or COVID-19 vaccination
2025 · Samira Bahrami, Behnaz Ansari, et al. · European journal of medical research · 3
Validation strategies for identifying drug targets in dermal fibrotic disorders
2021 · Leyla Norouzi-Barough, Ardeshir Bayat · Drug Discovery Today · 3
The physicochemical behavior of temozolomide stabilized on folic acid−targeted−gold−thiol modified surface via covalent conjugation towards cancer cells
2023 · Fatemeh Yaghoobi, Parisa Rashidiyan Harsini, et al. · Colloids and Surfaces A Physicochemical and Engineering Aspects · 1
IRF7 variants in fully vaccinated Iranian patients with severe COVID-19: a pilot observational study
2026 · Leyla Norouzi-Barough, Samira Bahrami, et al. · European journal of medical research
Dissecting the molecular heterogeneity of common variable immunodeficiency using an integrative multi-omics approach
2026 · Samira Bahrami, Fariba Dehghan, et al. · European journal of medical research
Treatment of Patients with Inborn Errors of Immunity Should Not Be Postponed Until Genetic Confirmation
2026 · Saba Fekrvand, Samanah Abdolahzadeh, et al. · Immunology and Genetics Journal
A National Consensus on Hematopoietic Stem Cell Transplantation for Patients with Inborn Errors of Immunity
2026 · Reza Yazdani, Samanah Abdolahzadeh, et al. · Immunology and Genetics Journal
A Systematic Review of Reported Fully Penetrant Sequence Variants and Clinical Characteristics in Association with 117 Patients with Single-gene Pyoderma Gangrenosum
2024 · Leyla Norouzi-Barough, Sajjad Biglari, et al.
PDF
体液循環腫瘍由来エキソソームによる乳癌および卵巣癌の早期診断【jst・京大機械翻訳】
2020 · Norouzi-Barough Leyla, Shahi Amir Asgari Khosro, et al.
Bioinformatics design of CRISPR guide RNA for genomic knockout of ABCB1 gene
2018 · Leyla Norouzi‐Barough, Mohammad Reza Sarookhani, et al. · qums (Qazvin University of Medical Sciences)
The study of effect of inhibiting the ABCB1 (P-gp) gene in reducing the resistance of cancer cells to the chemotherapeutic agent doxorubicin using CRISPR/Cas9 technology in ovarian cancer cell line A2780/ADR
2018 · Leyla Norouzi‐Barough
Works count: 20
Citation count: 347
H-index: 5
I10-index: 5
Year
Topic
Type